XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net loss $ (82,040) $ (11,975) $ (24,948)
Adjustments to reconcile net loss to net cash flows provided by operating activities:      
Depreciation and amortization 96,512 91,221 53,111
Share-based compensation expenses 64,331 74,921 127,957
Net loss (gain) from financing expenses (816) 4,476 (2,320)
Revaluation of the Warrants liability (627) (24,471) (22,656)
Amortization of loan and credit facility issuance costs 1,619 2,009 402
Amortization of premium and accretion of discount on short-term investments, net (914) (679) 0
Loss from disposal of property and equipment 1,571 0 0
Change in operating assets and liabilities:      
Increase in trade receivables, net (49,599) (11,242) (40,113)
Decrease (increase) in prepaid expenses and other current assets and long-term prepaid expenses 5,934 (10,785) (64,923)
Increase (decrease) in trade payables 36,563 (16,825) 23,862
Increase (decrease) in accrued expenses and other current liabilities and other long-term liabilities 25,202 (21,932) 16,182
Decrease in deferred taxes, net (15,496) (17,329) (1,581)
Change in operating lease right of use assets 16,830 15,528 14,529
Change in operating lease liabilities (14,697) (19,433) (15,981)
Net cash provided by operating activities 84,373 53,484 63,521
Cash flows from investing activities      
Purchase of property and equipment, including capitalized internal-use software (32,133) (34,914) (39,070)
Cash paid in connection with acquisitions, net of cash acquired 0 (7,981) (583,457)
Proceeds from (investment in) restricted deposits (730) 91 2,067
Proceeds from maturities of short-term investments 114,494 29,624 0
Purchase of short-term investments (21,991) (126,381) 0
Net cash provided by (used in) investing activities 59,640 (139,561) (620,460)
Cash flows from financing activities      
Exercise of options and vested RSUs 6,953 8,387 10,018
Issuance of Ordinary shares, net of offering costs 0 0 285,378
Payment of tax withholding for share-based compensation expenses (3,804) (5,751) (6,152)
Repurchase of Ordinary shares (55,513) 0 0
Proceeds from long-term loan, net of debt issuance costs 0 0 288,750
Repayment of long-term loan (82,250) (64,264) (750)
Costs associated with entering into a revolving credit facility 0 (1,245) 0
Issuance of Warrants 0 0 53,883
Net cash provided by (used in) financing activities (134,614) (62,873) 631,127
Exchange rate differences on balances of cash and cash equivalents 816 (4,476) 2,320
Increase (decrease) in cash and cash equivalents 10,215 (153,426) 76,508
Cash and cash equivalents - at the beginning of the period 165,893 319,319 242,811
Cash and cash equivalents - at the end of the period 176,108 165,893 319,319
Cash paid during the year for:      
Income taxes 18,011 28,798 15,475
Interest 18,488 20,712 1,125
Non-cash investing and financing activities:      
Purchase of property and equipment, including capitalized internal-use software 639 1,657 1,120
Share-based compensation included in capitalized internal-use software 2,253 1,932 783
Creation of operating lease right-of-use assets 11,730 17,269 4,520
Fair value of Ordinary shares issued as consideration of the acquisition 0 0 157,689
Issuance of Ordinary shares and Non-voting Ordinary shares related to Commercial agreement $ 288,063 $ 0 $ 0